Clinical Trial Update: Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2a trial evaluating the safety, tolerability, and efficacy of TOP1288 200 mg rectal solution once daily for 4 weeks in Ulcerative Colitis has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TOP1288

Snippet

Sponsor: Topivert Pharma Ltd | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED